Resistia
PrivateLast Round
Pre Seed
Oct 20, 2025
Total Funding Raised
$250,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Resistia is a biotechnology company developing bio-therapies based on microbiota compounds to target resistant biofilm-related infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resistia Comparables
Compare Resistia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTryp Therapeutics | 87% | |
| Disperazol Pharma ApS | 82% | |
| ProclaRx LLC | 81% | |
Resistia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 20, 2025 |
Resistia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRIDX | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2025
$250K round led by GRIDX
Resistia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resistia's valuation, stock price, and market status.